SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : momo-T/FIF
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biotech Jim who wrote (11440)12/21/2017 7:46:16 PM
From: Miljenko Zuanic  Read Replies (1) of 12215
 
<I wish that I had access to the long term tox reports. I would look at liver and kidney findings carefully if any. Do you know if there is a Data Monitoring Safety Board Committee for the NASH compound, and when those safety readouts will be?>

I guess, you are talking about VK2809. P2 Primary-H/NAFLD is 12 w (+ 4 w washout follow up), so my speculation is that there is no (??) DSMBC. 4 arms, 20 subjects per arm...trials is way overdue for enrolment completion as well as initial top line results. No interest??? Have no idea. Maybe they need to include Christmas gift package for every MDs visit!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News